The guideline committee of the Japan Society of Hepatology (JSH) have promptly updated the treatment guideline for the hepatitis C virus (HCV) after…

Many complications can occur during the evolution of chronic Hepatitis C virus (HCV) infection. Some of them can be…

Primary sclerosing cholangitis (PSC) is a rare, progressive, cholestatic, immune-mediated hepatobiliary disease. It is characterised by inflammation…

Hepatitis E virus (HEV) is endemic in many developed countries, with seroprevalence rates ranging from 4.7% in Scotland to 31.1% in France. Cases are…

The clinical application of hepatocyte transplants to treat patients with liver disease extends back to the early 1990s. Hepatocyte transplants are…

Nurses and specialist nurses are playing a growing role in the healthcare system. Alongside the specialities already existing, such as…

The main focus of training hepatology care is to gain skills and enable nurses to specialise in hepatology. Skills and specialisation are gained through…

Hepatocellular carcinoma (HCC) is currently the second most common cause of cancer-related death worldwide, with the majority of all cases of HCC…

Like it or hate it, social media, such as Twitter, Facebook, and Instagram, is having an impact on medicine. It is changing the way healthcare providers…

Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…